Silencing the Silent Risk Factor
Pelacarsen uses antisense technology to turn off the gene producing Lp(a). HORIZON results prove that lowering these 100% genetic levels prevents heart attacks in at-risk populations.
Strategic Data Expansion 2026.4
Genetic Lipidology
The first trial to show MACE reduction by targeting Lp(a). LSI keywords like 'antisense oligonucleotides' are defining the new guidelines.
Lp(a) Particle Reduction
Genomic Protection
$$\Delta R_{cv} \approx 0.22 imes \log(\Delta C_{lp})$$
Strategic Advice: Ask your doctor for a 'one-time' Lp(a) blood test to know your genetic risk.